Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity

References

• KnightTRFarissMWFarhoodAJaeschkeHRole of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in miceToxicol Sci200376122923612944590
   PubMed Web of Science ®Google Scholar
• ZimmermanHJMaddreyWCAcetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventureHepatology19952237677737657281
   PubMed Web of Science ®Google Scholar
• NolanCMSandblomREThummelKSlatteryJTNelsonSDHepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosisChest199410524084117508362
   PubMed Web of Science ®Google Scholar
• BreenKJBuryRWDesmondPVForgeBHMarshfordMLWhelanGParacetamol self-poisoning: diagnosis, management, and outcomeMed J Aust19821277797070335
   PubMed Web of Science ®Google Scholar
• DahlinDCMiwaGTLuAYNelsonSDN-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophenProc Natl Acad Sci U S A1984815132713316424115
   PubMed Web of Science ®Google Scholar
• VermeulenNPEBessemsJGMVan de StraatRMolecular aspect of paracetamol-induced hepatotoxicity and its mechanism based preventionDrug Metab Rev19922433674071628537
   PubMed Web of Science ®Google Scholar
• KaushalRDaveKRKatyareSSParacetamol hepatotoxicity and microsomal functionEnviron Toxicol Pharmacol199971677421781911
   PubMed Web of Science ®Google Scholar
• WagnerHDieselPSeitzMChemistry and analysis of silymarin from Silybum marianum GaertnArzneimittelforschung1974244466471 German.4408125
   PubMed Web of Science ®Google Scholar
• HahnGLehmannHDKurtenNUebelHVogelGOn the pharmacology and toxicology of silymarin, an antihepatotoxic active principle from Silybum marianum (L.) GaertnArzneimittelforschung1968186698704 [German].5755807
   PubMed Web of Science ®Google Scholar
• CorchetePSilybum marianum (L) Gaertn: the source of silymarinRamawatKGMerillonJMBioactive Molecules and Medicinal PlantsBerlin, GermanySpringer-Verlag2008124140
   Google Scholar
• LeeJINarayanMBarrettJSAnalysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography–electrospray ionization mass spectrometryJ Chromatogr B Analyt Technol Biomed life Sci2007845195103
   Web of Science ®Google Scholar
• ShibanoMLinASItokawaHLeeKHSeparation and characterization of active flavonolignans of Silybum marianum by liquid chromatography connected with hybrid ion-trap and time-of-flight mass spectrometry (LC-MS/IT-TOF)J Nat Prod20077091424142817764149
   PubMed Web of Science ®Google Scholar
• KvasnickaFBíbaBSevcíkRVoldrichMKrátkáJAnalysis of the active components of silymarinJ Chromatogr A20039901 Pt 223924512685603
   PubMed Web of Science ®Google Scholar
• RamasamyKAgarwalRMultitargeted therapy of cancer by silymarinCancer Lett2008269235236218472213
   PubMed Web of Science ®Google Scholar
• KaurMAgarwalRSilymarin and epithelial cancer chemoprevention: how close we are to bedside?Toxicol Appl Pharmacol2007224335035917184801
   PubMed Web of Science ®Google Scholar
• GabettaBBombardelliEPifferiG inventor; Inverni Della Beffa S.p.A., assignee. Complexes of flavonolignans with phospholipids, preparation thereof and associated pharmaceutical compositions. United States patent US 4764508.1988816
   Google Scholar
• MadausRHHalbachGTrostW inventor; Dr. Madaus and Co, assignee. Salt of the silymarin group with aminopolyhydroxy alcohols. United States patent US 3994925.19761130
   Google Scholar
• SchulzHUSchurerMKrumbiegelGWachterWWeyhenmeyerRSeidelGThe solubility and bioequivalence of silymarin preparationsArzneimittelforschung19954516164 [German].7893272
   PubMed Web of Science ®Google Scholar
• WooJSKimTSParkJHChiSCFormulation and biopharmaceutical evaluation of silymarin using SMEDDSArch Pharm Res2007301828917328246
   PubMed Web of Science ®Google Scholar
• ZhangHLBaiTCYanGBHuYJSolubility of silybin in aqueous poly(vinylpyrrolidone) solutionFluid Phase Equilibr20052382186192
   Web of Science ®Google Scholar
• ComoglioATomasiAMalandrinoSPoliGAlbanoEScavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicalsBiochem Pharmacol1995508131313167488251
   PubMed Web of Science ®Google Scholar
• EI-SamaligyAfifiNNMahmoudEAEvaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performanceInt J Pharm20063191 Pt 212112916837151
   PubMed Web of Science ®Google Scholar
• SonnenbichlerJMattersbergerJRosenHStimulation of RNA synthesis in rat liver and isolated hepatocytes by silybin, an antihepatotoxic agent from Silybum marianum L. GaertnHoppe Seylers Z Physiol Chem1976357811711180 [German].976944
   PubMedGoogle Scholar
• ShakerEMahmoudHMnaaSSilymarin, the antioxidant component and Silybum marianum extracts prevent liver damageFood Chem Toxicol201048380380620034535
   PubMed Web of Science ®Google Scholar
• SaliouCRihnBCillardJOkamotoTPackerLSelective inhibition of NF-kappa-B activation by the flavonoid hepatoprotector silymarin in HepG2: evidence for different activating pathwaysFEBS Lett19984401 Pt 28129862414
   PubMed Web of Science ®Google Scholar
• DehmlowCErhardJde GrootHInhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silybininHepatology19962347497548666328
   PubMed Web of Science ®Google Scholar
• CamposRGarridoAGuerraRValenzuelaASilybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liverPlanta Med19895554174192813577
   PubMed Web of Science ®Google Scholar
• MurielPGarciapinaTPerez-AlvarezVMourelleMSilymarin protects against paracetamol-induced lipid peroxidation and liver damageJ Appl Toxicol19921264394421360480
   PubMed Web of Science ®Google Scholar
• NenciniCGiorgiGMicheliLProtective effect of silymarin on oxidative stress in rat brainPhytomedicine2007142 Pt 312913516638633
   PubMed Web of Science ®Google Scholar
• UbrichNSchmidtCBodmeierRHoffmanMMaincentPOral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticlesInt J Pharm2005288116917515607269
   PubMed Web of Science ®Google Scholar
• PignatelloRBucoloCFerraraPMalteseAPuleoAPuglisiGEudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofenEur J Pharm Sci2002161 Pt 2536112113891
   PubMed Web of Science ®Google Scholar
• Galindo-RodriguezSAllémannEFessiHDoelkerEPhysicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methodsPharm Res20042181428143915359578
   PubMed Web of Science ®Google Scholar
• MillerRPFischerLJUrinary excretion of acetaminophen by the ratJ Pharm Sci19746369699704855343
   PubMed Web of Science ®Google Scholar
• PrescottLFFactors influencing paracetamol metabolismPrescottLFParacetamol (Acetaminophen): a Critical Bibliographic ReviewLondon, UKTaylor and Francis1996708715
   Google Scholar
• GovenderTStolnikSGarnettMCIllumLDavisSSPLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drugJ Control Release19995721711859971898
   PubMed Web of Science ®Google Scholar
• MaheshwariHAgarwalRPatilCKatareOPPreparation and pharmacological evaluation of silibinin liposomesArzneimittelforschung200353642042712872613
   PubMed Web of Science ®Google Scholar
• HinsonJAPikeSLPumfordNRMayeuxPRNitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in miceChem Res Toxicol19981166046079625727
   PubMed Web of Science ®Google Scholar
• SinghaPKRoySDeySProtective activity of andrographolide and arabinogalactan proteins from Andrographis paniculata Nees. against ethanol-induced toxicity in miceJ Ethnopharmacol20071111132117127022
   PubMed Web of Science ®Google Scholar
• EllmanGLTissue sulfhydryl groupsArch Biochem Biophys1959821707713650640
   PubMed Web of Science ®Google Scholar
• PignatelloRBucoloCPuglisiGOcular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug deliveryJ Pharm Sci200291122636264112434408
   PubMed Web of Science ®Google Scholar
• LanjuanLHuayingWZhanYOPolymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseasesNano Today201054296312
   Web of Science ®Google Scholar
• ArmstrongNAJamesKCPharmaceutical Experimental Design And InterpretationLondon, UKTaylor and Francis1996131134
   Google Scholar
• BellamyLJThe Infrared Spectra of Complex Molecules3rd ed1London, UKChapman and Hall1975107128
   Google Scholar
• LinCCMettersATHydrogels in controlled release formulations: network design and mathematical modelingAdv Drug Deliv Rev20065812 Pt 131379140817081649
   PubMed Web of Science ®Google Scholar
• LuCLuYChenJZhangWWuWSynchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix systemEur J Pharm Biopharm200766221021917196805
   PubMed Web of Science ®Google Scholar
• RoyPDasSBeraTMondolSMukherjeeAAndrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluationsInt J Nanomedicine201051113112121270962
   PubMed Web of Science ®Google Scholar
• BhowmikBBSaBMukherjeeAPreparation and in vitro characterization of slow release testosterone nanocapsules in alginatesActa Pharm20065641742919839134
   PubMedGoogle Scholar
• PignatelloRBucoloCSpedalieriGMalteseAPuglisiGFlurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic applicationBiomaterials200223153247325512102196
   PubMed Web of Science ®Google Scholar
• VandervoortJLudwigABiocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design studyInt J Pharm20022381 Pt 2779211996812
   PubMed Web of Science ®Google Scholar
• MurakamiHKawashimaYNiwaTHinoTTakeuchiHKobayashiMInfluence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(DL -lactide-co-glycolide) nanoparticleInt J Pharm19971494349
   Web of Science ®Google Scholar
• MinerDJKissingerPTEvidence for the involvement of N-acetyl-p-quinoneimine in acetaminophen metabolismBiochem Pharmacol1979282232853290526335
   PubMed Web of Science ®Google Scholar
• MitchellJRJollowDJPotterWZGilletteJRBrodieBBAcetaminophen-induced hepatic necrosis. IV. Protective role of glutathioneJ Pharmacol Exp Ther197318712112174746329
   PubMed Web of Science ®Google Scholar
• Martin-MurphyBVHoltMPJuCThe role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in miceToxicol Lett2010192338739419931603
   PubMed Web of Science ®Google Scholar
• BasiglioCLSánchez PozziEJMottinoADRomaMGDifferential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysisChem Biol Interact20091792 Pt 329730319135039
   PubMed Web of Science ®Google Scholar
• RobertsDWBucciTJBensonRWImmunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicityAm J Pathol199113823593711992763
   PubMed Web of Science ®Google Scholar
• WesolowskaOLania-PietrzakBKuzdzalMInfluence of silybin on biophysical properties of phospholipid bilayersActa Pharmacol Sin200728229630617241534
   PubMed Web of Science ®Google Scholar